• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于风险的成本效益分析评价饮用水系统中微生物风险缓解措施。

Risk-based cost-benefit analysis for evaluating microbial risk mitigation in a drinking water system.

机构信息

Chalmers University of Technology, Department of Architecture and Civil Engineering, SE-41296 Gothenburg, Sweden.

Chalmers University of Technology, Department of Architecture and Civil Engineering, SE-41296 Gothenburg, Sweden.

出版信息

Water Res. 2018 Apr 1;132:111-123. doi: 10.1016/j.watres.2017.12.054. Epub 2017 Dec 27.

DOI:10.1016/j.watres.2017.12.054
PMID:29316514
Abstract

Waterborne outbreaks of gastrointestinal diseases can cause large costs to society. Risk management needs to be holistic and transparent in order to reduce these risks in an effective manner. Microbial risk mitigation measures in a drinking water system were investigated using a novel approach combining probabilistic risk assessment and cost-benefit analysis. Lake Vomb in Sweden was used to exemplify and illustrate the risk-based decision model. Four mitigation alternatives were compared, where the first three alternatives, A1-A3, represented connecting 25, 50 and 75%, respectively, of on-site wastewater treatment systems in the catchment to the municipal wastewater treatment plant. The fourth alternative, A4, represented installing a UV-disinfection unit in the drinking water treatment plant. Quantitative microbial risk assessment was used to estimate the positive health effects in terms of quality adjusted life years (QALYs), resulting from the four mitigation alternatives. The health benefits were monetised using a unit cost per QALY. For each mitigation alternative, the net present value of health and environmental benefits and investment, maintenance and running costs was calculated. The results showed that only A4 can reduce the risk (probability of infection) below the World Health Organization guidelines of 10 infections per person per year (looking at the 95th percentile). Furthermore, all alternatives resulted in a negative net present value. However, the net present value would be positive (looking at the 50 percentile using a 1% discount rate) if non-monetised benefits (e.g. increased property value divided evenly over the studied time horizon and reduced microbial risks posed to animals), estimated at 800-1200 SEK (€100-150) per connected on-site wastewater treatment system per year, were included. This risk-based decision model creates a robust and transparent decision support tool. It is flexible enough to be tailored and applied to local settings of drinking water systems. The model provides a clear and holistic structure for decisions related to microbial risk mitigation. To improve the decision model, we suggest to further develop the valuation and monetisation of health effects and to refine the propagation of uncertainties and variabilities between the included methods.

摘要

水传播胃肠道疾病暴发会给社会带来巨大成本。为了有效地降低这些风险,风险管理需要具有整体性和透明性。本研究采用概率风险评估和成本效益分析相结合的新方法,调查了饮用水系统中的微生物风险缓解措施。瑞典的 Vomb 湖被用来举例说明基于风险的决策模型。比较了四种缓解方案,其中前三个方案 A1-A3 分别代表将集水区内 25%、50%和 75%的现场废水处理系统连接到城市废水处理厂,第四个方案 A4 代表在饮用水处理厂安装紫外线消毒装置。定量微生物风险评估用于估计四种缓解方案在质量调整生命年(QALY)方面的积极健康效益。使用每 QALY 的单位成本对健康效益进行货币化。对于每种缓解方案,都计算了健康和环境效益以及投资、维护和运行成本的净现值。结果表明,只有 A4 可以将风险(感染概率)降低到世界卫生组织规定的每人每年 10 次感染以下(考虑 95%分位数)。此外,所有方案的净现值均为负。然而,如果包括非货币化效益(例如,在研究时间范围内均匀分配给受研究人群的增加的财产价值以及降低对动物的微生物风险),则净现值为正(在 50%分位数使用 1%的贴现率),估计为每年每个连接的现场废水处理系统 800-1200 瑞典克朗(100-150 欧元)。这种基于风险的决策模型创建了一个稳健透明的决策支持工具。它足够灵活,可以根据饮用水系统的具体情况进行定制和应用。该模型为与微生物风险缓解相关的决策提供了一个清晰全面的结构。为了改进决策模型,我们建议进一步开发健康效益的评估和货币化,并改进包括方法之间的不确定性和可变性的传播。

相似文献

1
Risk-based cost-benefit analysis for evaluating microbial risk mitigation in a drinking water system.基于风险的成本效益分析评价饮用水系统中微生物风险缓解措施。
Water Res. 2018 Apr 1;132:111-123. doi: 10.1016/j.watres.2017.12.054. Epub 2017 Dec 27.
2
Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.地表水和地下水中污染物的来源、途径及相对风险:为沃克顿调查准备的一份报告
J Toxicol Environ Health A. 2002 Jan 11;65(1):1-142. doi: 10.1080/152873902753338572.
3
Sustainability assessments of regional water supply interventions - Combining cost-benefit and multi-criteria decision analyses.区域供水干预措施的可持续性评估 - 结合成本效益和多准则决策分析。
J Environ Manage. 2018 Nov 1;225:313-324. doi: 10.1016/j.jenvman.2018.07.077. Epub 2018 Aug 9.
4
Life cycle cost of a hybrid forward osmosis - low pressure reverse osmosis system for seawater desalination and wastewater recovery.海水淡化和废水回收用混合正向渗透-低压反渗透系统的生命周期成本。
Water Res. 2016 Jan 1;88:225-234. doi: 10.1016/j.watres.2015.10.017. Epub 2015 Oct 19.
5
A decision support system for drinking water production integrating health risks assessment.饮用水生产的决策支持系统,集成健康风险评估。
Int J Environ Res Public Health. 2014 Jul 18;11(7):7354-75. doi: 10.3390/ijerph110707354.
6
QMRA of adenovirus in drinking water at a drinking water treatment plant using UV and chlorine dioxide disinfection.紫外线和二氧化氯消毒饮用水处理厂中腺病毒的定量微生物风险评估。
Water Res. 2019 Jul 1;158:34-45. doi: 10.1016/j.watres.2019.03.090. Epub 2019 Apr 1.
7
Cost-effectiveness of nitrogen mitigation by alternative household wastewater management technologies.采用替代家庭废水管理技术减少氮排放的成本效益分析。
J Environ Manage. 2015 Mar 1;150:344-354. doi: 10.1016/j.jenvman.2014.10.002. Epub 2015 Jan 6.
8
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.多基因药物基因组学检测,包括用于指导抗抑郁药物选择的决策支持工具:一项卫生技术评估。
Ont Health Technol Assess Ser. 2021 Aug 12;21(13):1-214. eCollection 2021.
9
Fluence-based QMRA model for bacterial photorepair and regrowth in drinking water after decentralized UV disinfection.基于通量的 QMRA 模型用于分散式 UV 消毒后饮用水中细菌的光修复和再生长。
Water Res. 2023 Mar 1;231:119612. doi: 10.1016/j.watres.2023.119612. Epub 2023 Jan 15.
10
Comparison of PFAS soil remediation alternatives at a civilian airport using cost-benefit analysis.采用成本效益分析比较民用机场的 PFAS 土壤修复替代方案。
Sci Total Environ. 2023 Jul 15;882:163664. doi: 10.1016/j.scitotenv.2023.163664. Epub 2023 Apr 22.

引用本文的文献

1
Moving Beyond the Silos of Opportunistic Pathogen and Disinfection Byproduct Research to Improve Drinking Water System Management.超越机会性病原体和消毒副产物研究的局限,以改善饮用水系统管理。
Environ Sci Technol. 2025 May 13;59(18):8900-8921. doi: 10.1021/acs.est.4c12586. Epub 2025 May 2.
2
Changing climate and socio-economic conditions as part of quantitative microbial risk assessment of surface drinking water sources: a review.作为地表饮用水源定量微生物风险评估一部分的气候变化和社会经济条件:综述
J Water Health. 2025 Apr;23(4):507-528. doi: 10.2166/wh.2025.486. Epub 2025 Mar 20.
3
Research gaps and priorities for quantitative microbial risk assessment (QMRA).
定量微生物风险评估(QMRA)的研究空白和重点。
Risk Anal. 2024 Nov;44(11):2521-2536. doi: 10.1111/risa.14318. Epub 2024 May 21.
4
Multi-criteria decision analysis framework for engaging stakeholders in river pollution risk management.让利益相关者参与河流污染风险管理的多标准决策分析框架。
Sci Rep. 2024 Mar 26;14(1):7125. doi: 10.1038/s41598-024-57739-y.
5
Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer.基于风险的 COVID-19 替代疫苗在巴西的成本效益分析:科兴疫苗、阿斯利康疫苗与辉瑞疫苗。
Vaccine. 2022 Jun 21;40(28):3851-3860. doi: 10.1016/j.vaccine.2022.05.038. Epub 2022 May 19.